Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.

<h4>Background</h4>Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune responses, it is possible that antibodies could also mediate p...

Full description

Bibliographic Details
Main Authors: For Yue Tso, Salum J Lidenge, Lisa K Poppe, Phoebe B Peña, Sara R Privatt, Sydney J Bennett, John R Ngowi, Julius Mwaiselage, Michael Belshan, Jacob A Siedlik, Morgan A Raine, Juan B Ochoa, Julia Garcia-Diaz, Bobby Nossaman, Lyndsey Buckner, W Mark Roberts, Matthew J Dean, Augusto C Ochoa, John T West, Charles Wood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247640

Internet

https://doi.org/10.1371/journal.pone.0247640

Similar Items